1-5 of 5
Kashmira Wani
Close
Sort by
Journal Articles

Comparison of Maintenance Therapy Regimens of Patients Treated for Multiple Myeloma

Kashmira Wani, Radhika Gutta, Aayush Mittal, Maria Jamil, Kylie Springer, Philip Kuriakose
Journal: Blood
Blood (2023) 142 (Supplement 1): 6698.
https://doi.org/10.1182/blood-2023-189033
Published: 2023
Journal Articles

Impact of Race on Progression-Free Survival and Overall Survival in Patients with Multiple Myeloma

Kashmira Wani, Radhika Gutta, Aayush Mittal, Maria Jamil, Kylie Springer, Philip Kuriakose
Journal: Blood
Blood (2023) 142 (Supplement 1): 6661.
https://doi.org/10.1182/blood-2023-191157
Published: 2023
Journal Articles

Does Implementing Calendars Outlining Inpatient Chemotherapy Schedules in Patient Rooms Improve Patient's Experience?

Kashmira Wani, Vrushali S. Dabak
Journal: Blood
Blood (2023) 142 (Supplement 1): 7275.
https://doi.org/10.1182/blood-2023-185565
Published: 2023
Journal Articles

Incidence and Factors Associated with Hemophagocytic Lymphohistiocytosis Among Hospitalized Patients in the US Using a Large Nation-Wide Database

Rayli C. Pichardo, Yazan Abu Omar, Kashmira Wani, Kathren Shango, Philip Kuriakose
Journal: Blood
Blood (2022) 140 (Supplement 1): 11172–11173.
https://doi.org/10.1182/blood-2022-168312
Published: 2022
Journal Articles

Factors Associated with in-Hospital Mortality in Patients with Hemophagocytic Lymphohistiocytosis: A 5-Year Analysis from the National Inpatient Sample

Rayli C Pichardo, Kashmira Wani, Kathren Shango, Yazan Abu Omar, Philip Kuriakose
Journal: Blood
Blood (2022) 140 (Supplement 1): 7987–7988.
https://doi.org/10.1182/blood-2022-162922
Published: 2022